Vaxcyte raises $575M via convertible notes
- Raised $575M through 1.50% Convertible Senior Notes due 2032
- Notes mature on October 15, 2032
- Conversion rate of 11.1607 shares per $1,000 principal
PCVX
Vaxcyte, Inc. SEC filings
Every EDGAR filing for Vaxcyte, Inc. (PCVX), newest first, with AI summaries and stories.
- Ticker
- PCVX
- CIK
- 1649094
- Sector
- Biotech and pharma
- Latest filing
- Oct 9
Next: earnings expected ~Nov 6 · 10-Q expected ~Nov 6 (deadline Nov 9)
Insider activity
No open-market insider buys in the last 30 days.
Also: 4 open-market sales ($3.3M), 3 grants or exercises.
Filings
8-KVaxcyte, Inc.PCVXLIVE 4Vaxcyte, Inc.PCVXLIVE 2 insider filings
Elvia Cowan, insider filing for PCVX
Show all 2
- 4Insider filing for PCVX
- 4Insider filing for PCVX
Elvia Cowan, reporting
424B5Vaxcyte, Inc.PCVXLIVE 2 structured-note prospectuses
Securities offering
Show all 2
- 424B5Securities offering
- 424B5Securities offering
FWPVaxcyte, Inc.PCVXLIVE Vaxcyte, Inc. raises $959M
- 7,412,500 shares of common stock offered
- $500M in convertible notes due 2032
- Net proceeds to fund clinical trials and manufacturing
305B2Vaxcyte, Inc.PCVXLIVE Vaxcyte, Inc. files Form 305B2
- Filed on 2026-10-06
- U.S. Bank Trust Company, National Association as trustee
- Exhibits include Articles of Association and Bylaws
424B5Vaxcyte, Inc.PCVXLIVE 2 structured-note prospectuses
Securities offering
Show all 2
- 424B5Securities offering
- 424B5Securities offering
8-KVaxcyte, Inc.PCVXLIVE Vaxcyte reports positive trial results for VAX-31
- Phase 3 OPUS-1 trial met all primary endpoints
- VAX-31 showed noninferiority to PCV20 and PCV21
- VAX-31 was well tolerated with similar safety profile
144Vaxcyte, Inc.PCVXLIVE 2 Form 144 notices
Jim Wassil, planned sale of PCVX shares
Show all 2
- 144Planned insider sale of PCVX shares
- 144Planned insider sale of PCVX shares
Jim Wassil
4Vaxcyte, Inc.PCVXLIVE Vaxcyte, Inc. reports insider trading
- 10/01/2026: 2,250 shares acquired at $5.35
- 10/01/2026: 2,155 shares sold at $56.65
- 10/01/2026: 95 shares sold at $57.09
Jim Wassil
144Vaxcyte, Inc.PCVXLIVE Jim Wassil, planned sale of PCVX shares
Jim Wassil
4Vaxcyte, Inc.PCVXLIVE 7 insider filings
Grant Pickering, insider filing for PCVX
Show all 7
- 4Insider filing for PCVX
- 4Insider filing for PCVX
- 4Insider filing for PCVX
- 4Insider filing for PCVX
- 4Insider filing for PCVX
- 4Insider filing for PCVX
- 3New insider at PCVX
Grant Pickering, reporting
144Vaxcyte, Inc.PCVXLIVE Jim Wassil, planned sale of PCVX shares
Jim Wassil, reporting
144Vaxcyte, Inc.PCVXLIVE Jim Wassil, planned sale of PCVX shares
Jim Wassil, reporting
8-KVaxcyte, Inc.PCVXLIVE 4Vaxcyte, Inc.PCVXLIVE 5 insider filings
Jim Wassil, insider filing for PCVX
Show all 5
- 4Insider filing for PCVX
- 4Insider filing for PCVX
- 4Insider filing for PCVX
- 4Insider filing for PCVX
- 4Insider filing for PCVX
Jim Wassil, reporting
144Vaxcyte, Inc.PCVXLIVE Jim Wassil, planned sale of PCVX shares
Jim Wassil, reporting
SCHEDULE 13G/AVaxcyte, Inc.PCVXLIVE Ownership stake disclosure by Janus Henderson Group Ltd. (amended)
Janus Henderson Group Ltd., filed by
SCHEDULE 13G/AVaxcyte, Inc.PCVXLIVE Ownership stake disclosure by Janus Henderson Group Ltd. (amended)
Janus Henderson Group Ltd., filed by
SCHEDULE 13G/AVaxcyte, Inc.PCVXLIVE Ownership stake disclosure by FMR LLC (amended)
FMR LLC, filed by
4Vaxcyte, Inc.PCVXLIVE Harpreet S. Dhaliwal, insider filing for PCVX
Harpreet S. Dhaliwal, reporting
4Vaxcyte, Inc.PCVXLIVE 2 insider filings
Jim Wassil, insider filing for PCVX
Show all 2
- 4Insider filing for PCVX
- 4Insider filing for PCVX
Jim Wassil, reporting
10-QVaxcyte, Inc.PCVXLIVE 8-KVaxcyte, Inc.PCVXLIVE 144Vaxcyte, Inc.PCVXLIVE Harpreet S. Dhaliwal, planned sale of PCVX shares
Harpreet S. Dhaliwal, reporting
144Vaxcyte, Inc.PCVXLIVE 2 Form 144 notices
Andrew Guggenhime, planned sale of PCVX shares
Show all 2
- 144Planned insider sale of PCVX shares
- 144Planned insider sale of PCVX shares
Andrew Guggenhime, reporting
4Vaxcyte, Inc.PCVXLIVE Grant Pickering, insider filing for PCVX
Grant Pickering, reporting
144Vaxcyte, Inc.PCVXLIVE Grant Pickering, planned sale of PCVX shares
Grant Pickering, reporting
4Vaxcyte, Inc.PCVXLIVE 2 insider filings
John Markels, insider filing for PCVX
Show all 2
- 4Insider filing for PCVX
- 3New insider at PCVX
John Markels, reporting
8-KVaxcyte, Inc.PCVXLIVE 4Vaxcyte, Inc.PCVXLIVE Andrew Guggenhime, insider filing for PCVX
Andrew Guggenhime, reporting
4Vaxcyte, Inc.PCVXLIVE Jim Wassil, insider filing for PCVX
Jim Wassil, reporting
144Vaxcyte, Inc.PCVXLIVE Andrew Guggenhime, planned sale of PCVX shares
Andrew Guggenhime, reporting
144Vaxcyte, Inc.PCVXLIVE Jim Wassil, planned sale of PCVX shares
Jim Wassil, reporting